The global probiotic ingredients market is estimated to be valued at US$ 5,769 million in 2023. The market is projected to surpass a valuation of US$ 9,734.8 million by 2033, at an above-average CAGR of 6.4% from 2023. Here are some possible factors responsible for increasing the adoption of probiotic ingredients during the forecast period.
Scientific Advancements Broadening the Use Cases of Probiotic Ingredients:
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Antibiotics are highly effective in curing diseases within the least possible time, but their side effects are well-known and clear. The follow-up of anti-infection agents using a probiotic diet has gained importance over the years due to rising awareness among consumers. Consumption of a probiotic diet after antibiotic treatment results in the expansion of helpful microbes, which are likely to strengthen immunity and protect the body from further illnesses during recovery.
Probiotic supplements such as probioslim, florastor, and align are gaining popularity due to their unique probiotic ingredient types. Probioslim ingredients blend probiotics and prebiotics, while florastor ingredients contain a unique strain of probiotic yeast. On the other hand, Align probiotic supplement contains a strain of probiotics that is clinically proven to promote digestive health. The diverse types of probiotic ingredients and supplements available in the market are driving its growth, catering to the varied needs of consumers.
| Attributes | Details |
|---|---|
| Probiotic Ingredients Market Size Value in 2023 | US$ 5,769 million |
| Probiotic Ingredients Market Forecast Value in 2033 | US$ 9,734.8 million |
| Global Growth Rate (2023 to 2033) | 6.4% CAGR |
| Forecast Period | 2023 to 2033 |
Principal Consultant
Probiotics aid in fostering a healthy balance of intestinal bacteria, which has numerous positive effects on health. Atopic dermatitis, pediatric acute infectious diarrhea, irritable bowel syndrome, antibiotic-associated diarrhea, and obesity are some of the serious medical disorders that can be avoided by using probiotics.
The global probiotic ingredients market expanded by 4.0% during the first half of 2021. However, not all areas have seen this rise equally; the developing markets have seen a rate of growth of 6.4% (H1 2022 Expected). As a result, there will be a 244 BPS point difference between H1 2022's expected growth and predicted growth.
| Market Statistics | Details |
|---|---|
| H1,2021 (A) | 4.0% |
| H1,2022 Projected (P) | 4.0% |
| H1,2022 Outlook (O) | 6.4% |
| BPS Change : H1,2022 (O) - H1,2022 (P) | (+) 240 ↑ |
| BPS Change : H1,2022 (O) - H1,2021 (A) | (+) 244 ↑ |
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
| Top Product Type | Bacterial |
|---|---|
| CAGR % 2023 to End of Forecast (2033) | 5.6% |
The bacterial probiotic ingredients segment is projected to experience a CAGR of 5.6% from 2023 to 2033, emerging as the top product type. The dominance of bacterial probiotics can be attributed to their ability to improve gut health, boost the immune system, and aid digestion. Furthermore, the demand for bacterial probiotics is driven by the increasing popularity of dietary supplements that cater to specific health needs.
| Top End Use | Dietary Supplement |
|---|---|
| CAGR % 2023 to End of Forecast (2033) | 6.5% |
Among the end-use segments, dietary supplements are expected to witness the highest growth rate, with a CAGR of 6.5% from 2023 to 2033. The increasing focus on preventive healthcare and the need for functional foods that address specific health concerns are contributing to the growth of the dietary supplement segment. The probiotic ingredients market is experiencing significant growth, and the dominance of bacterial probiotics in the dietary supplement segment is expected to continue to fuel the market's expansion.
| United States Market Size (US$ million) by End of Forecast Period (2033) | US$ 1,288.7 million |
|---|---|
| CAGR % 2023 to End of Forecast (2033) | 5.9% |
The probiotic ingredients industry in the United States is expected to grow at a CAGR of 5.9% from 2023 to 2033, with an estimated market size of US$ 1,288.7 million. The market in the region is driven by increasing consumer awareness about the health benefits of probiotics and the rising demand for functional food and beverages.
In addition, the growing prevalence of digestive disorders and other chronic diseases is also propelling the demand for probiotic ingredients in the region. The United States is a major market for probiotic ingredients due to its large population, high healthcare expenditure, and high disposable income. Furthermore, the region is home to several leading probiotic ingredient manufacturers, making it a hub for product innovation and development.
| United Kingdom Market Size (US$ million) by End of Forecast Period (2033) | US$ 805.4 million |
|---|---|
| CAGR % 2023 to End of Forecast (2033) | 6.1% |
The United Kingdom probiotic ingredients industry is expected to be worth US$ 805.4 million by the end of the forecast period. The region is projected to witness substantial growth with a CAGR of 6.1% over the forecast period. The growing awareness of the health benefits of probiotics and increasing demand for natural and functional ingredients in the food and beverage industry are the primary drivers of this growth.
Moreover, the prevalence of digestive disorders and the rising trend of preventive healthcare are also fueling the demand for probiotic ingredients in the region. The increasing use of probiotics in animal nutrition and the development of innovative probiotic formulations are further expected to boost market growth in the United Kingdom.
| China Market Size (US$ million) by End of Forecast Period (2033) | US$ 735.0 million |
|---|---|
| CAGR % 2023 to End of Forecast (2033) | 6.7% |
China's probiotic ingredients industry is projected to reach US$ 735.0 million by the end of the forecast period. The market is expected to experience a CAGR of 6.7% from 2023 to 2033. The regional growth is propelled by several factors, such as the rising health consciousness among consumers, increasing demand for functional foods, and growing awareness of the health benefits associated with probiotics.
The Chinese government's initiatives to promote healthy food consumption and improve the quality of life for citizens are also contributing to the growth of the market. Additionally, the country's unique regional trends, such as the traditional use of probiotics in Chinese medicine, provide opportunities for innovative product development. With an aging population and an increasing prevalence of chronic diseases, the probiotic ingredients market in China is set to expand rapidly in the coming years.
| Germany Market Size (US$ million) by End of Forecast Period (2033) | US$ 644.3 million |
|---|---|
| CAGR % 2023 to End of Forecast (2033) | 8.5% |
Germany's probiotic ingredients industry is expected to reach a market size of US$ 644.3 million by the end of the forecast period. The demand for probiotic ingredients in Germany is anticipated to rise at a CAGR of 8.5% from 2023 to 2033. The growth is driven by the increasing demand for natural and functional foods as consumers become more aware of the health benefits associated with probiotics. The country's robust regulatory framework and strict quality standards for food products further boost the demand for probiotic ingredients.
Also, the aging population and rising prevalence of lifestyle diseases provide opportunities for the development of innovative probiotic products targeted at specific health concerns. The trend towards plant-based and vegan diets is also a major factor propelling the growth of the market in Germany. With the increasing importance of gut health and the growing interest in preventative health, the probiotic ingredients industry in Germany is expected to experience phenomenal growth in the coming years.
| Spain Market Size (US$ million) by End of Forecast Period (2033) | US$ 483.3 million |
|---|---|
| CAGR % 2023 to End of Forecast (2033) | 4.8% |
Spain's probiotic ingredients industry is projected to reach a valuation of US$ 483.3 million by the end of the forecast period. The sales of probiotic ingredients are anticipated to rise at a CAGR of 4.8% from 2023 to 2033. The growth of the market is propelled by factors such as increasing awareness of the health benefits of probiotics, the rise in health-conscious consumers, and the growing demand for natural and organic products.
The Spanish government's policies to promote healthy food consumption and regulate the use of probiotics in food products are also contributing to market growth. The country's unique regional trends, such as the popularity of the Mediterranean diet and traditional fermented foods like kefir, offer opportunities for innovative product development. With an aging population and increasing concerns over digestive health, Spain's probiotic ingredients market is expected to experience steady growth in the coming years.
Many local and regional players primarily characterise the global probiotic ingredients industry. Local players account for a fair share of 24-26%. North America and Europe are the two central target regions due to the increasing number of health-conscious consumers and demand for healthy food products.
Multinational players produce bacterial strains, process them, and channel them to the market through their established distribution channels. The market share accounted for by global players is low, only around 20-22%. All industry stakeholders, particularly in the high potential market but embryonic markets, are likely to collaborate or are in symbiotic relationships.
Food & beverage products fortified with gut health ingredients have gained significant consumer appeal, and probiotics lead the way. Recent studies allude to growing health platforms beyond digestive health, wherein probiotics are likely to achieve popular demand, such as GI disorder management and improving the immune system.
Opportunities abound in developed markets as probiotics spread to newer health categories, achieving newer claims. North America accounts for 50% of probiotic ingredients sold, led by robust consumer demand for products with targeted action and exemplary health outcomes.
On the other hand, Europe accounts for over one-third market share – sales remain complemented by a review of probiotic ingredients’ digestive health claims by the EFSA and other regulatory bodies in the region.
Developments in probiotic ingredients have come a long way, extending beyond their traditional use for improving digestive health to skin and oral health. The application scope of probiotics has grown to include the management of inflammatory bowel disease and irritable bowel syndrome. Evolution in the formulation of probiotic ingredients points to incorporating Halal and Kosher-certified products.
The food and beverage processing sector remains the leading consumer of probiotic ingredients, and the gains from dietary supplements are likely to remain significant. Livestock nutrition is emerging as another lucrative area for manufacturers, who are now rolling out new products targeting the personal care and cosmetics industry, although gains are marginal.
New changes that have occurred in these markets include:
| Attribute | Details |
|---|---|
| Market Size Value in 2023 | US$ 5,769 million |
| Market Forecast Value in 2033 | US$ 9,734.8 million |
| Global Growth Rate | 6.4% CAGR |
| Forecast Period | 2023 to 2033 |
| Historical Data Available for | 2017 to 2022 |
| Market Analysis | MT for Volume and US$ million for Value |
| Key Regions Covered | North America; Latin America; Europe; Japan; APEJ; Oceania and MEA |
| Key Countries Covered | United States, Canada, Brazil, Mexico, Argentina, EU5, Russia, Poland, China, ASEAN, Australia and New Zealand, Japan, GCC countries, Ethiopia, North Africa, South Africa, and others. |
| Key Market Segments Covered | Product Type, End-Use, End Product Form, Region |
| Key Companies Profiled | Chr. Hansen A/S; Danisco A/S (E.I. du Pont de Nemours & Company); Lallemand, Inc.; LeSaffre, S.A.; Probi AB; Novozymes A/S; Ganeden, Inc. (Kerry Plc); Probiotics International Ltd. (Archer Daniels Midland); DowDuPont Inc.; BioGaia AB; Sabinsa Corporation |
| Pricing | Available upon Request |
The global probiotic ingredients market is valued at US$ 5,769 million in 2023.
The United States is anticipated to be the leading consumer of probiotic ingredients, with a projected valuation of US$ 1,288.7 million by 2033.
With a projected CAGR of 5.6% through 2033, the bacterial probiotic ingredients segment is projected to emerge as the top product type.
The growing consumer preference for functional foods and dietary supplements promoting gut health is the current market trend.
Chr. Hansen A/S, Danisco A/S, Lallemand, Inc., LeSaffre, S.A., and Probi AB are the key players operating in the probiotic ingredients market.
1. Executive Summary | Probiotic Ingredients Market
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Product Life Cycle Analysis
3.5. Supply Chain Analysis
3.5.1. Supply Side Participants and their Roles
3.5.1.1. Producers
3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)
3.5.1.3. Wholesalers and Distributors
3.5.2. Value Added and Value Created at Node in the Supply Chain
3.5.3. List of Raw Material Suppliers
3.5.4. List of Existing and Potential Buyer’s
3.6. Investment Feasibility Matrix
3.7. Value Chain Analysis
3.7.1. Profit Margin Analysis
3.7.2. Wholesalers and Distributors
3.7.3. Retailers
3.8. PESTLE and Porter’s Analysis
3.9. Regulatory Landscape
3.9.1. By Key Regions
3.9.2. By Key Countries
3.10. Regional Parent Market Outlook
3.11. Production and Consumption Statistics
3.12. Import and Export Statistics
4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033
4.1. Historical Market Size Value (US$ Million) & Volume (MT) Analysis, 2018 to 2022
4.2. Current and Future Market Size Value (US$ Million) & Volume (MT) Projections, 2023 to 2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product Type
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) & Volume (MT) Analysis By Product Type, 2018 to 2022
5.3. Current and Future Market Size Value (US$ Million) & Volume (MT) Analysis and Forecast By Product Type, 2023 to 2033
5.3.1. Bacterial
5.3.1.1. Lactobacillus
5.3.1.2. Bacillus
5.3.1.3. Enterococcus
5.3.1.4. Bifidobacterium
5.3.1.5. Streptococcus
5.3.1.6. Others
5.3.2. Yeast
5.3.2.1. Saccharomyces Cerevisiae
5.3.2.2. Saccharomyces Boulardii
5.4. Y-o-Y Growth Trend Analysis By Product Type, 2018 to 2022
5.5. Absolute $ Opportunity Analysis By Product Type, 2023 to 2033
6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End Use
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) & Volume (MT) Analysis By End Use, 2018 to 2022
6.3. Current and Future Market Size Value (US$ Million) & Volume (MT) Analysis and Forecast By End Use, 2023 to 2033
6.3.1. Food & Beverages Processing
6.3.1.1. Bakery & Confectionery
6.3.1.2. Breakfast Solutions
6.3.1.3. Cultured Dairy Products
6.3.1.4. Ice Cream & Frozen Desserts
6.3.1.5. Snacks & Bars
6.3.1.6. Infant Nutrition
6.3.1.7. Beverages & Dairy Drinks
6.3.2. Dietary Supplements
6.3.2.1. Immune Health
6.3.2.2. Gut & Digestive Health
6.3.2.3. Women's Health
6.3.3. Personal Care & Cosmetics
6.3.4. Animal Feed
6.4. Y-o-Y Growth Trend Analysis By End Use, 2018 to 2022
6.5. Absolute $ Opportunity Analysis By End Use, 2023 to 2033
7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Form
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Million) & Volume (MT) Analysis By Form, 2018 to 2022
7.3. Current and Future Market Size Value (US$ Million) & Volume (MT) Analysis and Forecast By Form, 2023 to 2033
7.3.1. Powder
7.3.2. Granule
7.3.3. Capsule
7.3.4. Tablet/Chewable
7.3.5. Gel
7.4. Y-o-Y Growth Trend Analysis By Form, 2018 to 2022
7.5. Absolute $ Opportunity Analysis By Form, 2023 to 2033
8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region
8.1. Introduction
8.2. Historical Market Size Value (US$ Million) & Volume (MT) Analysis By Region, 2018 to 2022
8.3. Current Market Size Value (US$ Million) & Volume (MT) Analysis and Forecast By Region, 2023 to 2033
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. MEA
8.4. Market Attractiveness Analysis By Region
9. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
9.1. Historical Market Size Value (US$ Million) & Volume (MT) Trend Analysis By Market Taxonomy, 2018 to 2022
9.2. Market Size Value (US$ Million) & Volume (MT) Forecast By Market Taxonomy, 2023 to 2033
9.2.1. By Country
9.2.1.1. USA
9.2.1.2. Canada
9.2.2. By Product Type
9.2.3. By End Use
9.2.4. By Form
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Product Type
9.3.3. By End Use
9.3.4. By Form
9.4. Key Takeaways
10. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
10.1. Historical Market Size Value (US$ Million) & Volume (MT) Trend Analysis By Market Taxonomy, 2018 to 2022
10.2. Market Size Value (US$ Million) & Volume (MT) Forecast By Market Taxonomy, 2023 to 2033
10.2.1. By Country
10.2.1.1. Brazil
10.2.1.2. Mexico
10.2.1.3. Rest of Latin America
10.2.2. By Product Type
10.2.3. By End Use
10.2.4. By Form
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Product Type
10.3.3. By End Use
10.3.4. By Form
10.4. Key Takeaways
11. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
11.1. Historical Market Size Value (US$ Million) & Volume (MT) Trend Analysis By Market Taxonomy, 2018 to 2022
11.2. Market Size Value (US$ Million) & Volume (MT) Forecast By Market Taxonomy, 2023 to 2033
11.2.1. By Country
11.2.1.1. Germany
11.2.1.2. United Kingdom
11.2.1.3. France
11.2.1.4. Spain
11.2.1.5. Italy
11.2.1.6. Rest of Europe
11.2.2. By Product Type
11.2.3. By End Use
11.2.4. By Form
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Product Type
11.3.3. By End Use
11.3.4. By Form
11.4. Key Takeaways
12. Asia Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
12.1. Historical Market Size Value (US$ Million) & Volume (MT) Trend Analysis By Market Taxonomy, 2018 to 2022
12.2. Market Size Value (US$ Million) & Volume (MT) Forecast By Market Taxonomy, 2023 to 2033
12.2.1. By Country
12.2.1.1. China
12.2.1.2. Japan
12.2.1.3. South Korea
12.2.1.4. Singapore
12.2.1.5. Thailand
12.2.1.6. Indonesia
12.2.1.7. Australia
12.2.1.8. New Zealand
12.2.1.9. Rest of Asia Pacific
12.2.2. By Product Type
12.2.3. By End Use
12.2.4. By Form
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Product Type
12.3.3. By End Use
12.3.4. By Form
12.4. Key Takeaways
13. MEA Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
13.1. Historical Market Size Value (US$ Million) & Volume (MT) Trend Analysis By Market Taxonomy, 2018 to 2022
13.2. Market Size Value (US$ Million) & Volume (MT) Forecast By Market Taxonomy, 2023 to 2033
13.2.1. By Country
13.2.1.1. GCC Countries
13.2.1.2. South Africa
13.2.1.3. Israel
13.2.1.4. Rest of MEA
13.2.2. By Product Type
13.2.3. By End Use
13.2.4. By Form
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Product Type
13.3.3. By End Use
13.3.4. By Form
13.4. Key Takeaways
14. Key Countries Market Analysis
14.1. USA
14.1.1. Pricing Analysis
14.1.2. Market Share Analysis, 2022
14.1.2.1. By Product Type
14.1.2.2. By End Use
14.1.2.3. By Form
14.2. Canada
14.2.1. Pricing Analysis
14.2.2. Market Share Analysis, 2022
14.2.2.1. By Product Type
14.2.2.2. By End Use
14.2.2.3. By Form
14.3. Brazil
14.3.1. Pricing Analysis
14.3.2. Market Share Analysis, 2022
14.3.2.1. By Product Type
14.3.2.2. By End Use
14.3.2.3. By Form
14.4. Mexico
14.4.1. Pricing Analysis
14.4.2. Market Share Analysis, 2022
14.4.2.1. By Product Type
14.4.2.2. By End Use
14.4.2.3. By Form
14.5. Germany
14.5.1. Pricing Analysis
14.5.2. Market Share Analysis, 2022
14.5.2.1. By Product Type
14.5.2.2. By End Use
14.5.2.3. By Form
14.6. United Kingdom
14.6.1. Pricing Analysis
14.6.2. Market Share Analysis, 2022
14.6.2.1. By Product Type
14.6.2.2. By End Use
14.6.2.3. By Form
14.7. France
14.7.1. Pricing Analysis
14.7.2. Market Share Analysis, 2022
14.7.2.1. By Product Type
14.7.2.2. By End Use
14.7.2.3. By Form
14.8. Spain
14.8.1. Pricing Analysis
14.8.2. Market Share Analysis, 2022
14.8.2.1. By Product Type
14.8.2.2. By End Use
14.8.2.3. By Form
14.9. Italy
14.9.1. Pricing Analysis
14.9.2. Market Share Analysis, 2022
14.9.2.1. By Product Type
14.9.2.2. By End Use
14.9.2.3. By Form
14.10. China
14.10.1. Pricing Analysis
14.10.2. Market Share Analysis, 2022
14.10.2.1. By Product Type
14.10.2.2. By End Use
14.10.2.3. By Form
14.11. Japan
14.11.1. Pricing Analysis
14.11.2. Market Share Analysis, 2022
14.11.2.1. By Product Type
14.11.2.2. By End Use
14.11.2.3. By Form
14.12. South Korea
14.12.1. Pricing Analysis
14.12.2. Market Share Analysis, 2022
14.12.2.1. By Product Type
14.12.2.2. By End Use
14.12.2.3. By Form
14.13. Singapore
14.13.1. Pricing Analysis
14.13.2. Market Share Analysis, 2022
14.13.2.1. By Product Type
14.13.2.2. By End Use
14.13.2.3. By Form
14.14. Thailand
14.14.1. Pricing Analysis
14.14.2. Market Share Analysis, 2022
14.14.2.1. By Product Type
14.14.2.2. By End Use
14.14.2.3. By Form
14.15. Indonesia
14.15.1. Pricing Analysis
14.15.2. Market Share Analysis, 2022
14.15.2.1. By Product Type
14.15.2.2. By End Use
14.15.2.3. By Form
14.16. Australia
14.16.1. Pricing Analysis
14.16.2. Market Share Analysis, 2022
14.16.2.1. By Product Type
14.16.2.2. By End Use
14.16.2.3. By Form
14.17. New Zealand
14.17.1. Pricing Analysis
14.17.2. Market Share Analysis, 2022
14.17.2.1. By Product Type
14.17.2.2. By End Use
14.17.2.3. By Form
14.18. GCC Countries
14.18.1. Pricing Analysis
14.18.2. Market Share Analysis, 2022
14.18.2.1. By Product Type
14.18.2.2. By End Use
14.18.2.3. By Form
14.19. South Africa
14.19.1. Pricing Analysis
14.19.2. Market Share Analysis, 2022
14.19.2.1. By Product Type
14.19.2.2. By End Use
14.19.2.3. By Form
14.20. Israel
14.20.1. Pricing Analysis
14.20.2. Market Share Analysis, 2022
14.20.2.1. By Product Type
14.20.2.2. By End Use
14.20.2.3. By Form
15. Market Structure Analysis
15.1. Competition Dashboard
15.2. Competition Benchmarking
15.3. Market Share Analysis of Top Players
15.3.1. By Regional
15.3.2. By Product Type
15.3.3. By End Use
15.3.4. By Form
16. Competition Analysis
16.1. Competition Deep Dive
16.1.1. Chr. Hansen A/S
16.1.1.1. Overview
16.1.1.2. Product Portfolio
16.1.1.3. Profitability by Market Segments
16.1.1.4. Sales Footprint
16.1.1.5. Strategy Overview
16.1.1.5.1. Marketing Strategy
16.1.1.5.2. Product Strategy
16.1.1.5.3. Channel Strategy
16.1.2. Danisco A/S
16.1.2.1. Overview
16.1.2.2. Product Portfolio
16.1.2.3. Profitability by Market Segments
16.1.2.4. Sales Footprint
16.1.2.5. Strategy Overview
16.1.2.5.1. Marketing Strategy
16.1.2.5.2. Product Strategy
16.1.2.5.3. Channel Strategy
16.1.3. Lallemand, Inc.
16.1.3.1. Overview
16.1.3.2. Product Portfolio
16.1.3.3. Profitability by Market Segments
16.1.3.4. Sales Footprint
16.1.3.5. Strategy Overview
16.1.3.5.1. Marketing Strategy
16.1.3.5.2. Product Strategy
16.1.3.5.3. Channel Strategy
16.1.4. LeSaffre, S.A.
16.1.4.1. Overview
16.1.4.2. Product Portfolio
16.1.4.3. Profitability by Market Segments
16.1.4.4. Sales Footprint
16.1.4.5. Strategy Overview
16.1.4.5.1. Marketing Strategy
16.1.4.5.2. Product Strategy
16.1.4.5.3. Channel Strategy
16.1.5. Probi AB
16.1.5.1. Overview
16.1.5.2. Product Portfolio
16.1.5.3. Profitability by Market Segments
16.1.5.4. Sales Footprint
16.1.5.5. Strategy Overview
16.1.5.5.1. Marketing Strategy
16.1.5.5.2. Product Strategy
16.1.5.5.3. Channel Strategy
16.1.6. Novozymes A/S
16.1.6.1. Overview
16.1.6.2. Product Portfolio
16.1.6.3. Profitability by Market Segments
16.1.6.4. Sales Footprint
16.1.6.5. Strategy Overview
16.1.6.5.1. Marketing Strategy
16.1.6.5.2. Product Strategy
16.1.6.5.3. Channel Strategy
16.1.7. Ganeden, Inc.
16.1.7.1. Overview
16.1.7.2. Product Portfolio
16.1.7.3. Profitability by Market Segments
16.1.7.4. Sales Footprint
16.1.7.5. Strategy Overview
16.1.7.5.1. Marketing Strategy
16.1.7.5.2. Product Strategy
16.1.7.5.3. Channel Strategy
16.1.8. Probiotics International Ltd.
16.1.8.1. Overview
16.1.8.2. Product Portfolio
16.1.8.3. Profitability by Market Segments
16.1.8.4. Sales Footprint
16.1.8.5. Strategy Overview
16.1.8.5.1. Marketing Strategy
16.1.8.5.2. Product Strategy
16.1.8.5.3. Channel Strategy
16.1.9. DowDuPont Inc.
16.1.9.1. Overview
16.1.9.2. Product Portfolio
16.1.9.3. Profitability by Market Segments
16.1.9.4. Sales Footprint
16.1.9.5. Strategy Overview
16.1.9.5.1. Marketing Strategy
16.1.9.5.2. Product Strategy
16.1.9.5.3. Channel Strategy
16.1.10. BioGaia AB
16.1.10.1. Overview
16.1.10.2. Product Portfolio
16.1.10.3. Profitability by Market Segments
16.1.10.4. Sales Footprint
16.1.10.5. Strategy Overview
16.1.10.5.1. Marketing Strategy
16.1.10.5.2. Product Strategy
16.1.10.5.3. Channel Strategy
16.1.11. Sabinsa Corporation
16.1.11.1. Overview
16.1.11.2. Product Portfolio
16.1.11.3. Profitability by Market Segments
16.1.11.4. Sales Footprint
16.1.11.5. Strategy Overview
16.1.11.5.1. Marketing Strategy
16.1.11.5.2. Product Strategy
16.1.11.5.3. Channel Strategy
17. Assumptions & Acronyms Used
18. Research Methodology
Explore Food and Beverage Insights
View Reports
Probiotic Ingredients Market
